Koenig Scott 4

What Happened
Scott Koenig, a director of MacroGenics, had 15,831 restricted stock units convert into 15,831 shares on February 8, 2026 (reported as derivative conversion/exercise, code M). The filing shows an acquisition/conversion of 15,831 shares (acquisition price N/A) and a simultaneous disposition of 15,831 shares at $0.00. The $0.00 disposition typically reflects shares withheld to satisfy tax withholding or similar withholding obligations rather than an open‑market sale.

Key Details

• Transaction date: February 8, 2026; Form 4 filed Feb 10, 2026 (timely filing). Transaction code: M (exercise/conversion of derivative).
• Acquired: 15,831 shares via conversion (price N/A). Disposed: 15,831 shares at $0.00 (derivative).
• Shares owned after transaction: not disclosed in the provided filing data.
• Footnotes: F1 notes RSUs convert one-for-one into stock. F2 states the RSU grant was 95,000 on Feb 8, 2024; one‑third vested after one year, one‑half of the remaining units vested per a Separation Agreement on Aug 13, 2025, and the balance vests in two equal annual installments.
• No 10b5-1 plan or other special sale plan was reported in the provided details.

Context
These were RSU conversions (vesting-related) rather than a market purchase or voluntary cash sale. The simultaneous $0.00 disposal is commonly used to cover taxes or withholding obligations and does not necessarily indicate the insider sold shares for cash proceeds. For retail investors, vesting conversions are routine administrative events and do not by themselves signal a directional view on the company.